缩小字体
放大字体
更改字体
把本页添加到收藏夹
把本页用EMail发出
打印本页
TheFishSite Latest News
2007年 3月 1日 星期四
Print This Page Intervet sees 6% global growth
THE NETHERLANDS - Revenues at Intervet increased by 3% to EUR 1,125 million boosted by strong autonomous growth of 6% across all regions and product lines.
Outpacing market growth, EBIT before incidentals increased 2% to EUR 213 million, resulting in an EBIT margin of 18.9%. Divestments and acquisitions had a negative impact on revenues of 3%.
In Europe, autonomous growth was 5%, while in North America, revenues from ongoing operations grew 12%. At the end of the year, Intervet received important product approvals for Zilmax®, a feed additive for cattle and PreveNile®, a West Nile Virus vaccine for horses.
| TheFishSite News Desk | Read more Intervet News here |
